Acetylcysteine fine granules and preparation method thereof

By using coating layers of coating resin and anti-adhesive agents in acetylcysteine ​​fine granules, the problems of inconvenience, oxidation and odor in existing dosage forms are solved, and the stability of the drug and drug compliance are improved. , achieves rapid release and absorption.

CN118924700APending Publication Date: 2024-11-12ZHEJIANG LIBERI BIOPHARMACEUTICAL CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411324880.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-09-26
Filing Date
2024-09-23
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing acetylcysteine ​​drug dosage forms have shortcomings in swallowing, easy oxidation and odor, especially for patients with poor swallowing function and inconvenient water withdrawal, the elderly and children, and the efficacy and shelf life are short.

Method used

Develop acetylcysteine ​​fine granules by covering the coating layer outside the raw material layer, which contains coating resin and anti-adhesive agent, which contains nitrogen that can be combined with acetylcysteine. Atoms provide electron-donating groups for electrons, enhancing antioxidant and smell masking properties.

Benefits of technology

It improves the stability and swallowing convenience of acetylcysteine ​​fine granules, extends the shelf life of the drug, reduces the odor, and achieves rapid release and absorption. It is suitable for taking medicine for a variety of patient groups.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924700A_ABST
    Figure CN118924700A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of micronized coating, and particularly relates to acetylcysteine fine granules and a preparation method thereof.The acetylcysteine fine granules are composed of a raw material layer containing acetylcysteine and a coating layer coating the raw material layer, and the particle size of the acetylcysteine fine granules is smaller than 850 micrometers; the coating layer contains coating resin and an anti-sticking agent; the coating resin contains an electron donating group capable of providing electrons for nitrogen atoms in acetylcysteine for pairing. The acetylcysteine fine granules disclosed by the invention are small in particle size, so that the acetylcysteine fine granules are convenient for patients with poor swallowing functions to take. Meanwhile, the raw material layer of the acetylcysteine is coated with the coating layer, and coating resin in the coating layer is screened, so that the oxidation resistance of the acetylcysteine, the covering property of odor existing in the acetylcysteine and the swallowing convenience are further improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This application claims priority to Chinese patent application 2023112520398 filed on September 26, 2023, and the entire contents of the above specification are incorporated by reference in this application.

[0002] The invention belongs to the technical field of micronized coating, and particularly relates to acetylcysteine ​​fine granules and a preparation method thereof. Background Art

[0003] Acetylcysteine ​​is an essential amino acid for the synthesis of glutathione. It is a thiol-containing antioxidant with antioxidant and anti-inflammatory effects, and can protect the liver, lungs, heart and nerve cells. It is used to treat acute and chronic bronchitis and lung diseases caused by other reasons and associated with phlegm.

[0004] Acetylcysteine ​​has been included in the Chinese Pharmacopoeia as a mucolytic drug and is used as an expectorant in the treatment of acute and chronic bronchitis. Oral moderate doses (0.2-0.6 g / d) have been shown to have a positive effect. In addition to its cough-relieving and expectorant effects, oral acetylcysteine ​​also has a therapeutic effect on acute lung injury and acute myocardial infarction thrombolysis.

[0005] At present, the domestically marketed acetylcysteine ​​dosage forms include spray acetylcysteine, capsules, tablets, granules, etc., but these dosage forms are not very convenient for patients with poor swallowing function, difficulty in getting water, the elderly, and children to take the medicine. In order to solve the shortcomings of the above dosage forms, it is urgent to develop an acetylcysteine ​​fine granule to solve this problem.

[0006] Fine granules are a new type of oral solid preparation that has appeared in the domestic and international pharmaceutical markets in recent years. The characteristics of fine granules are that the drug is placed on the tongue and can be quickly swallowed without water or with only a small amount of water or chewing, so that it can be quickly released and absorbed in the body, thereby quickly achieving the purpose of treatment. At present, the pharmaceutical industry has increasingly higher requirements for the fineness of particles in raw materials and their preparations. With the improvement of international standards and the gradual modernization of Chinese medicine, fine particles, good efficacy and low dosage have become an inevitable trend.

[0007] However, acetylcysteine ​​is limited by its chemical structure, causing it to be easily oxidized and deteriorated in the air, and existing sprays, capsules, tablets, granules, etc. are usually difficult to completely isolate acetylcysteine ​​from air completely, causing the shelf life of its drug effect to be shorter, which is unfavorable for preservation. In addition, acetylcysteine ​​itself has a special smell similar to garlic because it contains amino and sulfydryl in its structure, so this feature reduces the compliance of patients taking acetylcysteine ​​medicine. Therefore, the problem of acetylcysteine ​​being easily oxidized and having a bad smell must be solved simultaneously in the development process of acetylcysteine ​​fine granules. Summary of the invention

[0008] The present invention aims to overcome the shortcomings of the prior art acetylcysteine ​​pharmaceutical dosage form, such as being inconvenient to swallow, being easily oxidized by oxygen, and having a bad smell that is difficult to conceal. Therefore, an acetylcysteine ​​fine granule and a preparation method thereof are provided to overcome the above shortcomings.

[0009] To achieve the above-mentioned purpose, the present invention is implemented by the following technical solutions: In a first aspect, the present invention first provides an acetylcysteine ​​fine granule, It consists of a raw material layer containing acetylcysteine ​​and a coating layer coated on the outside of the raw material layer, and its particle size is less than 850 microns; The coating layer contains a coating resin and an anti-sticking agent; The coating resin contains an electron-donating group capable of providing electrons for pairing with the nitrogen atom in acetylcysteine.

[0010] The acetylcysteine ​​fine granules in the present application have a smaller particle size range than the capsules, tablets, granules, etc. in the prior art. Therefore, during the administration process, it is only necessary to place the medicine on the tongue, without water or only a small amount of water, and without chewing, and it can be quickly swallowed, thereby effectively facilitating the medication of patients, the elderly, and children with poor swallowing function and difficulty in obtaining water.

[0011] At the same time, the acetylcysteine ​​fine granules in the present application are coated with a coating layer on the outside of the acetylcysteine ​​raw material layer, so it can isolate acetylcysteine ​​from the external environment to a certain extent, thereby effectively improving the stability of acetylcysteine. At the same time, the setting of the coating layer can isolate the unpleasant smell of acetylcysteine ​​to a certain extent, thereby improving the compliance of patients when taking acetylcysteine ​​fine granules.

[0012] In addition, the inventors of the present application have found in experiments that the composition materials of the coating layer have an important influence on the antioxidant performance and taste-masking performance of the acetylcysteine ​​fine granules. Although there are many coating materials in the prior art, not all coating materials are applicable to the acetylcysteine ​​fine granules described in the present application.

[0013] Specifically, in the present application, the inventors found that if the coating resin in the coating layer contains an electron-donating group that provides electrons for pairing with acetylcysteine, it can greatly improve the antioxidant performance, taste-masking performance and easy-to-swallow performance of acetylcysteine ​​fine particles.

[0014] The reason is that the stink in acetylcysteine ​​comes from the amino and sulfhydryl groups in its molecular structure, and in addition, acetylcysteine ​​also contains a carboxyl group, and these three groups all contain active hydrogen atoms. Therefore, the coating resin selected for use in the present application contains an electron-donating group, so the electron-donating group in the coating resin can be paired with the amino, sulfhydryl and carboxyl groups in acetylcysteine ​​during the coating process, thereby greatly improving the coverage rate of acetylcysteine ​​and the bonding strength between acetylcysteine ​​and the coating resin. At the same time, when the amino and sulfhydryl groups in acetylcysteine ​​are combined with the coating resin, these amino and N atoms in the sulfhydryl groups and the sulfur atoms can obtain electrons, thereby tending to a steady state to prevent the dissemination of bad taste.

[0015] Such a configuration brings the following benefits: (1) it avoids the extravasation of acetylcysteine ​​due to insufficient coating rate, which causes oxidation of acetylcysteine ​​and makes it difficult to conceal its odor; (2) since the binding strength between acetylcysteine ​​and the coating resin is relatively high, the antioxidant property of the coated acetylcysteine ​​is improved, thereby preventing oxygen from penetrating into the coating layer; (3) since there are electron-donating groups in the coating resin, it can also play a good binding role with water, thereby improving the affinity of acetylcysteine ​​fine granules with water, so that the acetylcysteine ​​fine granules in the present application can be moistened only by the moisture in the oral cavity, further improving the swallowing convenience of acetylcysteine ​​fine granules; (4) finally, after acetylcysteine ​​is combined with the coating resin, it will not dissociate under near-neutral pH conditions and room temperature conditions, but when it enters the stomach, it will quickly dissociate under strongly acidic conditions, thereby achieving rapid release of acetylcysteine.

[0016] Therefore, in summary, the acetylcysteine ​​fine granules in the present application are convenient for patients with poor swallowing function to take due to their small particle size. At the same time, by coating the outer surface of the raw material layer of acetylcysteine ​​with a coating layer and screening the coating resin in the coating layer, the antioxidant performance of acetylcysteine, the masking of the odor of acetylcysteine ​​itself, and the convenience of swallowing are further improved.

[0017] Preferably, the composition ratio between the raw material layer and the coating layer is: Raw material layer 70-90% Coating layer 10-30%.

[0018] The acetylcysteine ​​fine granules in the present application limit the weight ratio of the coating layer to the raw material layer. When the weight ratio of the coating layer is too low, the coating thickness will be too thin or even unable to completely coat the acetylcysteine, resulting in leakage of acetylcysteine ​​and a decrease in oxidation resistance. However, when the weight ratio of the coating layer is too high, the coating layer will be too thick, slowing down the release rate of acetylcysteine ​​and failing to achieve a rapid release effect.

[0019] Preferably, the electron donating group in the coating resin is any one of a dialkylamine group, a hydroxyl group and an alkoxy group.

[0020] The electron donating group selected for use in the present application is any one of dialkyl amido, hydroxyl and alkoxyl groups, and the reason is that these groups all have lone pairs of electrons, and electrons can be given to the acetylcysteine ​​molecule. From the perspective of molecular orbital theory, this electron giving can make the energy of the highest occupied molecular orbital (HOMO) of the acetylcysteine ​​molecule rise, and the electron cloud density increases. For oxygen, this type of oxidant, it needs to seize electrons from the oxidized substance in the oxidation reaction. After the electron cloud density of the acetylcysteine ​​molecule increases, oxygen is just difficult to seize electrons from its molecule, thereby reduces the oxidized possibility of acetylcysteine.

[0021] The nitrogen atom in the dialkylamine group has a lone pair of electrons, which can donate electrons to the acetylcysteine ​​molecule. From the perspective of molecular orbital theory, this electron donation will increase the energy of the highest occupied molecular orbital (HOMO) of the acetylcysteine ​​molecule and increase the electron cloud density. This adjustment of the electronic structure will enhance the overall chemical stability of the acetylcysteine ​​molecule, reduce the tendency to undergo redox reactions with oxygen, and protect acetylcysteine ​​from oxidation. For oxidants such as oxygen, it needs to take electrons from the oxidized substance in the oxidation reaction. When the electron cloud density of the acetylcysteine ​​molecule increases, it is difficult for oxygen to take electrons from its molecule, thereby reducing the possibility of acetylcysteine ​​being oxidized.

[0022] In addition, these electron-donating groups can enhance the interaction between the coating resin and acetylcysteine. From a physical and chemical point of view, the interaction between molecules includes van der Waals forces, hydrogen bonds, etc. Dialkylamine groups, hydroxyl groups, and alkoxy groups can form hydrogen bonds or enhance van der Waals forces, so that the coating resin can better adhere to the surface of the acetylcysteine ​​raw material layer, improve the integrity and stability of the coating layer, and thus better protect the drug.

[0023] In addition, the presence of these electron-donating groups may affect the release process of the drug in vivo. They may interact with the biological environment in the body (such as certain components in body fluids) to regulate the dissolution rate or permeability of the coating layer. For example, hydroxyl groups may form hydrogen bonds with water molecules. Under appropriate conditions, this interaction may affect the dissolution rate of the coating layer, thereby controlling the release rate of acetylcysteine ​​to achieve an ideal drug efficacy mode.

[0024] These electron-donating groups not only give the coating resin antioxidant and improve physical and chemical properties, but also help to mask the odor of the amino and thiol groups in acetylcysteine. They may achieve the effect of masking the odor by changing the chemical structure and surface properties of the coating layer, reducing the rate and amount of odorous molecules diffusing through the coating layer to the outside world.

[0025] Preferably, the coating resin is one or more of polyacrylic acid resin and hydroxypropyl methylcellulose.

[0026] Preferably, the polyacrylic acid resin is Eudragit EPO.

[0027] Preferably, the anti-sticking agent is any one of talc and glyceryl mono- and distearate.

[0028] In this application, talcum powder has good lubricity and hydrophobicity. In the coating layer of fine granules, talcum powder can form a thin isolation layer on the surface of the particles, reducing the direct contact area between the particles, thereby reducing the adhesion between the particles. This helps to prevent the fine granules from sticking together during storage and transportation, and ensures the fluidity and operability of the drug. And mono- and di-stearate glyceryl is a surfactant with dual properties of lipophilicity and hydrophilicity. In the coating layer, it can reduce the surface energy of the particle surface, making it difficult for the particles to stick to each other. At the same time, it can also improve the uniformity and smoothness of the coating layer and improve the appearance quality of the drug.

[0029] Preferably, the mesh size of the anti-sticking agent is greater than or equal to 1000 meshes.

[0030] The inventors of the present application have found that the mesh size of the anti-adherent agent has an important influence on the performance of the overall fine granules. It has been found in practice that when the mesh size of the anti-adherent agent is greater than or equal to 1000 meshes, the anti-adherent agent particles are very fine. During the coating process, these fine particles can be more evenly dispersed in the coating layer and fully mixed with the coating resin. This makes the texture of the coating layer more uniform, avoiding the problem of local adhesion or unstable performance caused by uneven distribution of the anti-adherent agent. At the same time, good dispersibility also helps to improve the uniformity of coverage of the coating layer on the raw material layer, thereby better playing a protective role.

[0031] At the same time, high-mesh anti-adhesives have a larger specific surface area. This means that at the same mass, they can contact more particle surfaces and provide better anti-adhesive properties. Fine particles can be more tightly filled in the gaps between particles, forming a more effective isolation layer, further reducing the adhesion between fine particles and ensuring that the drug maintains good fluidity during storage and transportation.

[0032] In addition, due to the small particles of high-mesh anti-adherent agents, they can make the surface of the coating layer smoother and more delicate. This not only improves the appearance quality of the drug, but also reduces the wear and tear of the coating layer during use. The smooth surface also helps to reduce the friction between the drug and the external environment, reducing the possibility of the drug being affected by external factors.

[0033] Preferably, the raw material layer further comprises a coating resin and an anti-sticking agent, and the coating resin and the anti-sticking agent are less than 1% of the mass of acetylcysteine ​​in the raw material layer.

[0034] The acetylcysteine ​​fine granules in the present application contain a certain amount of coating resin and anti-adherent in the raw material layer, because the coating resin and anti-adherent can effectively improve the stability, antioxidant performance and taste-masking performance of the acetylcysteine ​​in the raw material layer. Meanwhile, the acetylcysteine ​​fine granules are also easy to be formed.

[0035] In a second aspect, the present invention also provides a method for preparing the acetylcysteine ​​fine granules, comprising the following steps: (S.1) crushing and sieving the acetylcysteine ​​API to obtain API powder; (S.2) adding the anti-adherent agent and the coating resin into water and homogenizing to obtain a coating premix; (S.3) adding acetylcysteine ​​API powder to a fluidized bed for preheating, and after the preheating is completed, introducing a coating premix liquid into the fluidized bed, and controlling the speed of the injected liquid and the volatilized liquid to be equal, thereby coating a coating layer on the surface of the acetylcysteine ​​API; (S.4) Drying and sieving the coated material to obtain the acetylcysteine ​​fine granules.

[0036] In the present application step (S.3), coating operation is carried out in a fluidized bed, and acetylcysteine ​​bulk drug powder is in a fluidized state, and each particle can be fully exposed to the spraying of the coating premix liquid. Meanwhile, the liquid sprayed into is controlled to be equivalent to the liquid speed of volatilization, so that the coating material can be uniformly deposited on the bulk drug surface, forming a coating layer with uniform thickness, effectively improving the stability and controllability of the drug. In addition, the bulk drug powder surface temperature after preheating is relatively uniform, which is conducive to the attachment and drying of coating materials. The bonding force between the coating layer formed under such conditions and the bulk drug is stronger, and it is not easy to occur that the coating layer falls off or breaks, thereby ensuring the coating quality.

[0037] Preferably, in the step (S.1), the acetylcysteine ​​raw material is crushed to 120-150 mesh.

[0038] Preferably, the solid content of the coating premix in step (S.2) is 25-30%.

[0039] The inventors of the present application have found that the fluidity and viscosity of the coating premix are moderate after the solid content of the coating premix is ​​set to 25-30%. During the coating process, it can be sprayed on the surface of the acetylcysteine ​​API powder more evenly to form a coating layer with uniform thickness and stable quality. If the solid content is too high, the premix may be too viscous, resulting in uneven spraying and inconsistent coating thickness; if the solid content is too low, the coating layer may be too thin and unable to fully play the role of protecting the API, masking odor and preventing oxidation.

[0040] In addition, the drying time of the coating premix with a solid content of 25-30% after spraying is relatively reasonable. It will not take too long to dry due to too high a moisture content, affecting production efficiency, nor will it dry too fast due to too low a moisture content, which may cause problems such as cracking of the coating layer. In this way, production efficiency can be improved and production costs can be reduced while ensuring coating quality.

[0041] Finally, the thickness and properties of the coating layer will affect the release rate of the drug in the body, and the choice of solid content can indirectly adjust parameters such as the thickness and porosity of the coating layer. A solid content of 25-30% can give the coating layer appropriate permeability, thereby achieving a sustained or controlled release effect of the drug and improving the efficacy and safety of the drug.

[0042] Preferably, the preheating temperature in step (S.3) is 40°C-55°C, the atomization pressure of the coating premix is ​​0.2-0.4 bar, the introduction temperature of the coating premix is ​​35-38°C, and the wind speed is maintained at 10-20 m 3 / h, liquid feeding speed 0.5-2g / min.

[0043] Preferably, the step (S.3) further comprises the step of wetting the acetylcysteine ​​raw material powder with a coating premix solution before adding the acetylcysteine ​​raw material powder to the fluidized bed, wherein the mass ratio of the acetylcysteine ​​raw material powder to the coating premix solution is 100:0.5-2.

[0044] Pre-wetting the acetylcysteine ​​API powder in the coating process can make the powder surface have a certain degree of contact with the coating material before entering the fluidized bed for coating. When the powder enters the fluidized bed, this pre-contact can promote the uniform distribution of the coating premix on the powder surface, thereby improving the uniformity of the coating. If there is no pre-wetting, the powder surface may have uneven properties, resulting in uneven adhesion of the coating material during the coating process.

[0045] At the same time, the wetting step allows the API powder to form a preliminary bond with the coating premix. This bond can be further strengthened during the subsequent fluidized bed coating process, thereby increasing the bonding strength between the coating layer and the API powder. This helps ensure that the coating layer is not easy to fall off during storage, transportation and use, ensuring the stability and effectiveness of the drug.

[0046] In addition, the appropriate mass ratio ensures that the powder surface can be fully wetted without causing powder agglomeration or affecting fluidization due to excessive coating premix. Within the mass ratio range of 100:0.5-2, a good foundation can be laid for the subsequent coating process without affecting the fluidity of the powder.

[0047] Therefore, the present invention has the following beneficial effects: (1) The acetylcysteine ​​fine granules in the present application have a small particle size and can be quickly swallowed with water or only a small amount of water, without chewing, thereby effectively facilitating the medication of patients, the elderly, and children with poor swallowing function and difficulty in obtaining water; (2) The coating layer outside the acetylcysteine ​​raw material layer can isolate acetylcysteine ​​from the external environment, thereby effectively improving the stability of acetylcysteine; (3) The selection of ingredients in the coating layer can effectively isolate the unpleasant smell of acetylcysteine, thereby improving the patient's compliance when taking acetylcysteine ​​fine granules, and at the same time improving the antioxidant properties of the coated acetylcysteine, thereby preventing oxygen from penetrating into the coating layer. BRIEF DESCRIPTION OF THE DRAWINGS

[0048] Figure 1 It is a microscope photo of the acetylcysteine ​​bulk drug powder in Example 1 of the present invention.

[0049] Figure 2This is a microscope photograph of the acetylcysteine ​​fine granules prepared in Example 1 of the present invention. DETAILED DESCRIPTION

[0050] The present invention is further described below in conjunction with specific embodiments. Those of ordinary skill in the art will be able to implement the present invention based on these descriptions. In addition, the embodiments of the present invention involved in the following description are generally only embodiments of a part of the present invention, rather than all embodiments. Therefore, based on the embodiments in the present invention, all other embodiments obtained by those of ordinary skill in the art without making creative work should fall within the scope of protection of the present invention.

[0051] Example 1 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of polyacrylic acid resin (Eutrac EPO powder) into water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 50° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 36° C., and the wind speed is maintained at 15 m / s. 3 / h, the liquid feeding speed is 1g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 80:20; (S.4) The coated material was dried at 60° C. for 50 min, and then passed through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules. The microscopic photograph of the prepared acetylcysteine ​​fine granules is as follows: Figure 2 shown.

[0052] Example 2 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of hydroxypropyl cellulose to water, and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 50° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 36° C., and the wind speed is maintained at 15 m / s. 3 / h, the liquid feeding speed is 1g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 80:20; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0053] Example 3 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of polyvinyl pyrrolidone into water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 50° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 36° C., and the wind speed is maintained at 15 m / s. 3 / h, the liquid feeding speed is 1g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 80:20; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0054] Example 4 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 5 g of 1250 mesh glyceryl monostearate and 20 g of polyacrylic acid resin (Eutrac EPO powder) to water and homogenizing to obtain a coating premix with a solid content of 30%; (S.3) The acetylcysteine ​​API powder is uniformly mixed with a coating premix liquid accounting for 0.5% of the acetylcysteine ​​API powder for pre-wetting, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed for preheating to 40° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.2 bar, the introduction temperature of the coating premix liquid is 35° C., and the wind speed is maintained at 10 m 3 / h, the liquid feeding speed is 0.5g / min, so that the speed of the liquid sprayed in is controlled to be equal to the speed of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 70:30; (S.4) Dry the coated material at 50° C. for 60 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0055] Example 5 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 8 g of talc powder with a particle size of 1250 mesh and 30 g of polyacrylic acid resin (Eutrac EPO powder) into water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 2% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 55° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.4 bar, the introduction temperature of the coating premix liquid is 38° C., and the wind speed is maintained at 20 m 3 / h, the liquid feeding speed is 2g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 90:10; (S.4) Dry the coated material at 80° C. for 45 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0056] Comparative Example 1 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of ethyl cellulose to water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 50° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 36° C., and the wind speed is maintained at 15 m / s. 3 / h, the liquid feeding speed is 1g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 80:20; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0057] Comparative Example 2 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of cellulose acetate phthalate to water, and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 50° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 36° C., and the wind speed is maintained at 15 m / s. 3 / h, the liquid feeding speed is 1g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 80:20; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0058] Comparative Example 3 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 800 mesh and 25 g of polyacrylic acid resin (Eutrac EPO powder) into water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 50° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 36° C., and the wind speed is maintained at 15 m / s. 3 / h, the liquid feeding speed is 1g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 80:20; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0059] Comparative Example 4 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of polyacrylic acid resin (Eutrac EPO powder) into water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 65° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 45° C., and the wind speed is maintained at 25 m / s. 3 / h, and the liquid feeding speed is 1.5g / min, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 80:20; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0060] Comparative Example 5 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of polyacrylic acid resin (Eutrac EPO powder) into water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix solution accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 35° C. After the preheating is completed, the coating premix solution is introduced into the fluidized bed, the atomization pressure of the coating premix solution is 0.2 bar, the introduction temperature of the coating premix solution is 30° C., and the wind speed is maintained at 20 m 3 / h, and the liquid feeding speed is 0.5g / min, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 80:20; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0061] Comparative Example 6 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of polyacrylic acid resin (Eutrac EPO powder) into water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 50° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 36° C., and the wind speed is maintained at 15 m / s. 3 / h, the liquid feeding speed is 1g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 95:5; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0062] Comparative Example 7 An acetylcysteine ​​fine granule, the preparation method of which comprises the following steps: (S.1) Crush the acetylcysteine ​​raw material and pass it through a 120-150 mesh sieve to obtain Figure 1 Acetylcysteine ​​API powder as shown; (S.2) adding 7 g of talc powder with a particle size of 1250 mesh and 25 g of polyacrylic acid resin (Eutrac EPO powder) into water and homogenizing to obtain a coating premix with a solid content of 25%; (S.3) The acetylcysteine ​​API powder and the coating premix liquid accounting for 1% of the acetylcysteine ​​API powder are uniformly mixed and pre-wetted, and then the pre-wetted acetylcysteine ​​API powder is transported to a fluidized bed and preheated to 50° C. After the preheating is completed, the coating premix liquid is introduced into the fluidized bed, the atomization pressure of the coating premix liquid is 0.3 bar, the introduction temperature of the coating premix liquid is 36° C., and the wind speed is maintained at 15 m / s. 3 / h, the liquid feeding speed is 1g / min, so that the speed of the liquid sprayed in is controlled to be equal to that of the volatilized liquid, thereby coating a coating layer on the surface of the acetylcysteine ​​raw material, and the composition ratio between the raw material layer and the coating layer is 70:30; (S.4) Dry the coated material at 60° C. for 50 min, and then pass it through an 80-mesh sieve to obtain the acetylcysteine ​​fine granules.

[0063] The acetylcysteine ​​fine granules prepared in Examples 1-5 and Comparative Examples 1-7 were tested, and the test method is as follows: 1. Antioxidant performance test method: (1) Place the finished coated products in the following environments: Table 1

[0064] (2) Use the content detection method of acetylcysteine ​​granules in the "Chinese Pharmacopoeia 2020 Edition": [Content determination] Determine according to high performance liquid chromatography (General Rule 0512).

[0065] Solvent: Sodium metabisulfite solution (1→2000).

[0066] Test solution: Take 10 bags of this product, transfer all the contents to a 500ml volumetric flask, add an appropriate amount of solvent, shake to dissolve and dilute to the scale, shake well, accurately measure 25ml, put it in a 100ml (0.1g specification) or 200ml (0.2g specification) volumetric flask, dilute the scale with solvent, shake well, filter, and take the filtrate; Reference solution: Take about 50 mg of acetylcysteine ​​reference substance, weigh accurately, place in a 100 ml volumetric flask, add solvent to dissolve and dilute to the scale, shake well; Chromatographic conditions: octadecylsilane bonded silica gel as filler; 0.05 mol / L potassium ammonium phosphate solution (pH adjusted to 3.0 with phosphoric acid) as mobile phase; detection wavelength at 214 nm; injection volume 20 ul; System suitability requirements: The number of theoretical plates calculated based on the acetylcysteine ​​peak is not less than 1000.

[0067] Determination method: Accurately measure the test solution and the reference solution, inject them into the liquid chromatograph respectively, record the chromatogram, and calculate the peak area according to the external standard method.

[0068] Test the content before placement: test the content 3 days, 7 days, 15 days, and 30 days after placement, and make a final comparison.

[0069] 2. Odor masking performance test method: Qualitative odor test method - sniffing method, which is divided into individual sniffing and collective sniffing: Individual sniffing method: One person alone smells the finished product in a fixed space and evaluates it; Group sniffing method: The group sniffs the finished product in a fixed space and evaluates it.

[0070] 3. Drug release test method under different pH environments: The same batch of acetylcysteine ​​fine granules were subjected to drug dissolution and release experiments at pH 4.7 and pH 7.

[0071] Dissolution: Determine according to the dissolution and release method (General Rule 0931 Method 1).

[0072] Dissolution conditions: Use 500 ml of pH 4.7 acetate buffer (take 200 ml of 1 mol / L acetic acid solution, add 600 ml of water, mix well, adjust the pH value to 4.7±0.05 with 1 mol / L sodium hydroxide solution, and dilute to 1000 ml with water) as the dissolution medium, the rotation speed is 100 revolutions per minute, operate according to the method, and sample after 30 minutes.

[0073] Test solution: Take an appropriate amount of the dissolution solution, filter it, and take the filtrate.

[0074] Reference solution: Take about 20 mg of acetylcysteine ​​reference substance, accurately weigh it, place it in a 100 ml volumetric flask, add an appropriate amount of methanol to dissolve it, and dilute it with dissolution medium until it is well mixed; accurately measure 2 ml, place it in a 100 ml volumetric flask, dilute it to the scale with dissolution medium, and shake it well.

[0075] The test results of the acetylcysteine ​​fine granules prepared in Examples 1-5 and Comparative Examples 1-7 are shown in Table 2-5 below: Table 2

[0076] Table 3

[0077] Table 4

[0078] Table 5

[0079] As can be seen from the data in the above table, the acetylcysteine ​​fine granules prepared in Examples 1-5 in the present application have good cold and hot stability. After storage at room temperature, low temperature and high temperature, the acetylcysteine ​​fine granules still have a high acetylcysteine ​​content, indicating that the acetylcysteine ​​prepared in the present application has good storage performance. After comparing Example 1 with Comparative Example 1 and Comparative Example 2, we found that the selection of the coating resin in the coating material has an important influence on its storage performance, odor masking performance and drug release test under different pH environments. When the coating resin lacks an electron-donating group that can provide electrons for pairing in acetylcysteine, its performance will be greatly reduced.

[0080] By comparing Example 1 with Comparative Example 3, we found that the particle size of the anti-adhesive agent (talcum powder) also has an important influence on the acetylcysteine ​​fine particles. When the particle size of the anti-adhesive agent is too large, its performance will decline to a certain extent.

[0081] By comparing Example 1 with Comparative Examples 4 and 5, we found that after adjusting the parameters of the fluidized bed, it was impossible to achieve the purpose of controlling the speed of the sprayed liquid and the volatilized liquid to be equal during the coating process, resulting in uneven coating and decreased taste masking performance.

[0082] By comparing Example 1 with Comparative Examples 6 and 7, we found that when the thickness of the coating layer in the acetylcysteine ​​fine granules is low, it will have adverse consequences on the antioxidant performance, taste masking performance and drug release performance of the acetylcysteine ​​fine granules. When the thickness of the coating layer is too high, the release rate of the drug after entering the body will be significantly reduced, which is not conducive to the rapid onset of the drug.

[0083] The specific embodiments described herein are merely examples of the spirit of the present invention. A person skilled in the art of the present invention may make various modifications or additions to the specific embodiments described or replace them in a similar manner, but this will not deviate from the spirit of the present invention or exceed the scope defined by the appended claims.

Claims

1. An acetylcysteine ​​fine granule, characterized in that: It consists of a raw material layer containing acetylcysteine ​​and a coating layer coated on the outside of the raw material layer, and its particle size is less than 850 microns; The coating layer contains a coating resin and an anti-sticking agent; The coating resin contains an electron-donating group capable of providing electrons for pairing in acetylcysteine.

2. The acetylcysteine ​​fine granules according to claim 1, characterized in that: The composition ratio between the raw material layer and the coating layer is: Raw material layer 70-90% Coating layer 10-30%.

3. The acetylcysteine ​​fine granules according to claim 1, characterized in that: The electron donating group in the coating resin is any one of a dialkylamine group, a hydroxyl group and an alkoxy group.

4. A kind of acetylcysteine ​​fine granules according to claim 1 or 2, characterized in that, The coating resin is one or more of polyacrylic acid resin and hydroxypropyl methylcellulose.

5. The acetylcysteine ​​fine granules according to claim 1, characterized in that: The anti-sticking agent is any one of talc and glyceryl mono- and distearate; The mesh number of the anti-sticking agent is greater than or equal to 1000 meshes.

6. The acetylcysteine ​​fine granules according to claim 1, characterized in that: The raw material layer also contains coating resin and anti-sticking agent, and the coating resin and anti-sticking agent are less than 1% of the mass of acetylcysteine ​​in the raw material layer.

7. A method for preparing the acetylcysteine ​​fine granules as claimed in any one of claims 1 to 6, characterized in that: The following steps are involved: (S.1) crushing and sieving the acetylcysteine ​​API to obtain API powder; (S.2) adding the anti-adherent agent and the coating resin into water and homogenizing to obtain a coating premix; (S.3) adding acetylcysteine ​​API powder to a fluidized bed for preheating, and after the preheating is completed, introducing a coating premix liquid into the fluidized bed, and controlling the speed of the injected liquid and the volatilized liquid to be equal, thereby coating a coating layer on the surface of the acetylcysteine ​​API; (S.4) Drying and sieving the coated material to obtain the acetylcysteine ​​fine granules.

8. The method according to claim 7, characterized in that The solid content of the coating premix in step (S.2) is 25-30%.

9. The method according to claim 7, characterized in that: In the step (S.3), the preheating temperature is 40-55°C, the atomization pressure of the coating premix is ​​0.2-0.4 bar, the introduction temperature of the coating premix is ​​35-38°C, and the wind speed is maintained at 10-20 m 3 / h, liquid feeding speed 0.5-2g / min.

10. The method according to claim 7 or 9, characterized in that: The step (S.3) further comprises the step of wetting the acetylcysteine ​​raw material powder with a coating premix solution before adding the acetylcysteine ​​raw material powder to the fluidized bed, wherein the mass ratio of the acetylcysteine ​​raw material powder to the coating premix solution is 100:0.5-2.

Citation Information

Patent Citations

  • Acetylcysteine quick-release particle and preparation method thereof

    CN117643579A